DPPN-SVM: Computational Identification of Mis-Localized Proteins in Cancers by Integrating Differential Gene

Guang-Ping Li1, Pu-Feng Du1, Zi-Ang Shen1

  • 1College of Intelligence and Computing, Tianjin University, Tianjin, China.

Frontiers in Genetics
|November 16, 2020
PubMed

Insights

Identifying cancer-related mis-localized proteins is crucial for understanding cancer pathology and developing therapies. This study introduces a novel computational model, DPPN-SVM, to accurately identify these mis-localized proteins using dynamic protein-protein interaction networks.

Area of Science:

  • Cell biology
  • Bioinformatics
  • Computational oncology

Background:

  • Eukaryotic cells possess subcellular compartments essential for protein function.
  • Mis-localization of proteins is implicated in the development of various cancers.
  • Experimental methods for determining protein localization are resource-intensive.

Purpose of the Study:

  • To computationally identify cancer-related mis-localized proteins.
  • To develop a predictive model integrating gene expression and dynamic protein-protein interactions.
  • To improve the identification of mis-localized proteins compared to existing methods.

Main Methods:

  • Development of the DPPN-SVM (Dynamic Protein-Protein Network with Support Vector Machine) model.
  • Integration of gene expression profiles and dynamic protein-protein interaction networks.
  • Utilizing a Support Vector Machine (SVM) classifier with diffusion kernels for prediction.

Main Results:

  • Identification of a significant number of mis-localized proteins associated with cancer.
  • Demonstration of the DPPN-SVM model's enhanced capability in identifying mis-localized proteins.
  • Establishment of a novel approach incorporating dynamic protein-protein interaction networks.

Conclusions:

  • The DPPN-SVM model offers a powerful computational tool for identifying cancer-related mis-localized proteins.
  • Incorporating dynamic protein-protein interaction networks significantly improves the accuracy of mis-localized protein identification.
  • This approach holds promise for advancing cancer research and therapeutic development.